NO20003108D0 - Anvendelse av melatoninenergiske ligander ved fremstilling av farmasøytiske sammensetninger - Google Patents

Anvendelse av melatoninenergiske ligander ved fremstilling av farmasøytiske sammensetninger

Info

Publication number
NO20003108D0
NO20003108D0 NO20003108A NO20003108A NO20003108D0 NO 20003108 D0 NO20003108 D0 NO 20003108D0 NO 20003108 A NO20003108 A NO 20003108A NO 20003108 A NO20003108 A NO 20003108A NO 20003108 D0 NO20003108 D0 NO 20003108D0
Authority
NO
Norway
Prior art keywords
melatonin
preparation
pharmaceutical compositions
energetic
ligands
Prior art date
Application number
NO20003108A
Other languages
English (en)
Other versions
NO20003108L (no
Inventor
Sonia Pellissier
Anne Merle
Philippe Delagrange
Caroline Bennejean
Pierre Renard
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO20003108D0 publication Critical patent/NO20003108D0/no
Publication of NO20003108L publication Critical patent/NO20003108L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20003108A 1999-06-23 2000-06-16 Anvendelse av melatoninenergiske ligander ved fremstilling av farmasöytiske sammensetninger NO20003108L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9908019A FR2795323B1 (fr) 1999-06-23 1999-06-23 Utilisation de ligands melatoninergiques pour l'obtention de compositions pharmaceutiques destinees a la prevention ou au traitement des pathologies du systeme gastrointestinal

Publications (2)

Publication Number Publication Date
NO20003108D0 true NO20003108D0 (no) 2000-06-16
NO20003108L NO20003108L (no) 2000-12-27

Family

ID=9547206

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003108A NO20003108L (no) 1999-06-23 2000-06-16 Anvendelse av melatoninenergiske ligander ved fremstilling av farmasöytiske sammensetninger

Country Status (15)

Country Link
EP (1) EP1064941A1 (no)
JP (1) JP2001026539A (no)
KR (1) KR20010039680A (no)
CN (1) CN1283455A (no)
AU (1) AU4264800A (no)
BR (1) BR0002772A (no)
CA (1) CA2312432A1 (no)
EA (1) EA002823B1 (no)
FR (1) FR2795323B1 (no)
HU (1) HUP0002377A3 (no)
MX (1) MXPA00006145A (no)
NO (1) NO20003108L (no)
NZ (1) NZ505361A (no)
PL (1) PL340954A1 (no)
ZA (1) ZA200003165B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050249785A1 (en) * 2003-08-13 2005-11-10 Gordon John G Use of melatonin-containing oral supplement with animals
CN1870992A (zh) 2003-10-03 2006-11-29 维伊林股份有限公司 动物饲料组合物
DE60336934D1 (de) * 2003-10-03 2011-06-09 Veijlen N V Verwendung von igf-1-serumspiegel-erhöhenden indolessigsäure-derivaten zur herstellung eines arzneimittels zur behandlung von verschiedenen krankheiten
EP1997488A4 (en) * 2006-03-20 2010-04-21 Takeda Pharmaceutical AGENT FOR THE PREVENTION / TREATMENT OF IRRITABLE COLON SYNDROME
ES2384798B1 (es) * 2011-10-19 2013-06-04 Universidad De Granada Uso de melatonina para el tratamiento y/o prevención de la mucositis.
RU2693044C1 (ru) * 2018-05-28 2019-07-01 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский Университет) ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Сеч Способ профилактики нпвп-гастропатии
WO2022157564A1 (en) * 2021-01-23 2022-07-28 Cellix Bio Private Limited A pharmaceutical composition comprising famotidine, lidocaine and melatonin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2729147A1 (fr) * 1995-01-11 1996-07-12 Adir Nouveaux composes (hetero) cycliques alkyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
FR2795323A1 (fr) 2000-12-29
EA002823B1 (ru) 2002-10-31
EA200000568A3 (ru) 2001-02-26
CN1283455A (zh) 2001-02-14
PL340954A1 (en) 2001-01-02
HUP0002377A2 (hu) 2002-05-29
NO20003108L (no) 2000-12-27
HUP0002377A3 (en) 2002-08-28
KR20010039680A (ko) 2001-05-15
MXPA00006145A (es) 2002-10-17
NZ505361A (en) 2002-02-01
JP2001026539A (ja) 2001-01-30
CA2312432A1 (fr) 2000-12-23
FR2795323B1 (fr) 2001-11-16
AU4264800A (en) 2001-01-04
EA200000568A2 (ru) 2000-12-25
ZA200003165B (en) 2001-01-25
EP1064941A1 (fr) 2001-01-03
BR0002772A (pt) 2001-01-30

Similar Documents

Publication Publication Date Title
DE60024988D1 (de) Herstellung von therapeutischem mikroschaum
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
PT1233943E (pt) Formulações para agentes farmacêuticos ionizáveis como ácidos livres ou bases livres
NO20015175D0 (no) Farmasöytisk sammensetning
NO20014379L (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
EE04965B1 (et) Imidasoimidasoolid ja triasoolid kui p?letikuvastased hendid, nende kasutamine ravimite valmistamiseks ning farmatseutiline kompositsioon
PT1242087E (pt) Composicoes farmaceuticas
FI991485A (fi) Uusi farmaseuttinen koostumus
NO20015112D0 (no) Anvendelse av glykosylceramidsynteseinhibitorer ved terapi
PL356180A1 (en) Hair treatment compositions comprising particulate substances
EE200100536A (et) Amiini-plaatina komplekside valmistamismeetod
EE05020B1 (et) Glburiidi ravimkoostis
HUP0203311A2 (hu) Új nyújtott hatású gyógyszerkészítmények
DE60019960D1 (de) Herstellung von isobutencopolymere
NO20020358L (no) Anvendelse av etodolac til behandling av kreft
HK1058201A1 (en) Novel indole derivatives and their use as medicaments
PT1239832E (pt) Composicoes farmaceuticas
BR0012184B1 (pt) compostos derivados de indol, formulação farmacêutica, e, composição e uso dos compostos na fabricação de medicamentos
NO20003108D0 (no) Anvendelse av melatoninenergiske ligander ved fremstilling av farmasøytiske sammensetninger
IS6172A (is) Notkun melatoníns til lækninga
DK1150681T3 (da) Anvendelse af en farmaceutisk sammensætning indeholdende desoxypeganin til behandling af nikotinafhængighed
FI4488U1 (fi) Farmaseuttinen koostumus
NO20014081D0 (no) Anvendelse av tianeptin i produksjonen av medikamenter til behandling av nevrodegenerative patologier
IL137275A0 (en) Pharmaceutical composition for the treatment of anal fissures
IL147410A0 (en) L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application